ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/01/16 | 1,380 | 1,380 | 1,380 | 1,380 | -6 | -0.4% | 1,000 |
| 2013/01/15 | 1,390 | 1,400 | 1,383 | 1,386 | -3 | -0.2% | 18,000 |
| 2013/01/11 | 1,410 | 1,415 | 1,378 | 1,389 | -21 | -1.5% | 24,000 |
| 2013/01/10 | 1,436 | 1,436 | 1,410 | 1,410 | -26 | -1.8% | 20,000 |
| 2013/01/09 | 1,417 | 1,439 | 1,412 | 1,436 | +16 | +1.1% | 15,000 |
| 2013/01/08 | 1,431 | 1,433 | 1,420 | 1,420 | -18 | -1.3% | 20,000 |
| 2013/01/07 | 1,453 | 1,453 | 1,438 | 1,438 | -15 | -1% | 11,000 |
| 2013/01/04 | 1,432 | 1,459 | 1,432 | 1,453 | +22 | +1.5% | 28,000 |
| 2012/12/28 | 1,449 | 1,450 | 1,430 | 1,431 | -4 | -0.3% | 26,000 |
| 2012/12/27 | 1,420 | 1,442 | 1,420 | 1,435 | +17 | +1.2% | 20,000 |
| 2012/12/26 | 1,425 | 1,431 | 1,418 | 1,418 | +10 | +0.7% | 8,000 |
| 2012/12/25 | 1,450 | 1,450 | 1,385 | 1,408 | -10 | -0.7% | 32,000 |
| 2012/12/21 | 1,413 | 1,420 | 1,399 | 1,418 | +5 | +0.4% | 18,000 |
| 2012/12/20 | 1,398 | 1,413 | 1,380 | 1,413 | -15 | -1.1% | 17,000 |
| 2012/12/19 | 1,390 | 1,435 | 1,388 | 1,428 | +41 | +3% | 17,000 |
| 2012/12/18 | 1,400 | 1,400 | 1,381 | 1,387 | -13 | -0.9% | 8,000 |
| 2012/12/17 | 1,381 | 1,400 | 1,381 | 1,400 | +33 | +2.4% | 19,000 |
| 2012/12/14 | 1,357 | 1,367 | 1,350 | 1,367 | +21 | +1.6% | 39,000 |
| 2012/12/13 | 1,380 | 1,380 | 1,335 | 1,346 | -16 | -1.2% | 19,000 |
| 2012/12/12 | 1,335 | 1,362 | 1,335 | 1,362 | +17 | +1.3% | 8,000 |
| 2012/12/11 | 1,342 | 1,345 | 1,340 | 1,345 | +16 | +1.2% | 6,000 |
| 2012/12/10 | 1,335 | 1,342 | 1,329 | 1,329 | +23 | +1.8% | 21,000 |
| 2012/12/07 | 1,293 | 1,310 | 1,293 | 1,306 | +13 | +1% | 5,000 |
| 2012/12/06 | 1,310 | 1,324 | 1,282 | 1,293 | +11 | +0.9% | 27,000 |
| 2012/12/05 | 1,273 | 1,282 | 1,273 | 1,282 | +10 | +0.8% | 10,000 |
| 2012/12/04 | 1,268 | 1,273 | 1,268 | 1,272 | +1 | +0.1% | 11,000 |
| 2012/12/03 | 1,280 | 1,280 | 1,271 | 1,271 | -5 | -0.4% | 14,000 |
| 2012/11/30 | 1,278 | 1,278 | 1,276 | 1,276 | +3 | +0.2% | 9,000 |
| 2012/11/29 | 1,274 | 1,279 | 1,265 | 1,273 | ±0 | ±0% | 14,000 |
| 2012/11/28 | 1,277 | 1,282 | 1,271 | 1,273 | +3 | +0.2% | 15,000 |
| 2012/11/27 | 1,280 | 1,283 | 1,269 | 1,270 | -8 | -0.6% | 38,000 |
| 2012/11/26 | 1,280 | 1,282 | 1,277 | 1,278 | -1 | -0.1% | 16,000 |
| 2012/11/22 | 1,282 | 1,284 | 1,272 | 1,279 | +4 | +0.3% | 12,000 |
| 2012/11/21 | 1,280 | 1,280 | 1,275 | 1,275 | +6 | +0.5% | 3,000 |
| 2012/11/20 | 1,280 | 1,280 | 1,269 | 1,269 | -15 | -1.2% | 7,000 |
| 2012/11/19 | 1,242 | 1,289 | 1,242 | 1,284 | +35 | +2.8% | 10,000 |
| 2012/11/16 | 1,230 | 1,253 | 1,222 | 1,249 | +15 | +1.2% | 17,000 |
| 2012/11/15 | 1,216 | 1,234 | 1,216 | 1,234 | +19 | +1.6% | 18,000 |
| 2012/11/14 | 1,205 | 1,226 | 1,205 | 1,215 | -7 | -0.6% | 6,000 |
| 2012/11/13 | 1,236 | 1,236 | 1,212 | 1,222 | -20 | -1.6% | 20,000 |
| 2012/11/12 | 1,240 | 1,253 | 1,227 | 1,242 | +2 | +0.2% | 20,000 |
| 2012/11/09 | 1,246 | 1,246 | 1,222 | 1,240 | -6 | -0.5% | 7,000 |
| 2012/11/08 | 1,270 | 1,270 | 1,246 | 1,246 | -21 | -1.7% | 13,000 |
| 2012/11/07 | 1,279 | 1,279 | 1,253 | 1,267 | -1 | -0.1% | 12,000 |
| 2012/11/06 | 1,280 | 1,280 | 1,267 | 1,268 | -12 | -0.9% | 6,000 |
| 2012/11/05 | 1,280 | 1,280 | 1,267 | 1,280 | -5 | -0.4% | 8,000 |
| 2012/11/02 | 1,280 | 1,292 | 1,280 | 1,285 | +11 | +0.9% | 14,000 |
| 2012/11/01 | 1,278 | 1,278 | 1,274 | 1,274 | ±0 | ±0% | 15,000 |
| 2012/10/31 | 1,241 | 1,274 | 1,241 | 1,274 | +34 | +2.7% | 17,000 |
| 2012/10/30 | 1,262 | 1,264 | 1,240 | 1,240 | -38 | -3% | 22,000 |
2901～
2950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
